Artículos de revistas sobre el tema "PDE"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "PDE".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bloom, Timothy J. "Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle". Canadian Journal of Physiology and Pharmacology 80, n.º 12 (1 de diciembre de 2002): 1132–35. http://dx.doi.org/10.1139/y02-149.
Texto completoDAY, Jonathan P., Julian A. T. DOW, Miles D. HOUSLAY y Shireen-A. DAVIES. "Cyclic nucleotide phosphodiesterases in Drosophila melanogaster". Biochemical Journal 388, n.º 1 (10 de mayo de 2005): 333–42. http://dx.doi.org/10.1042/bj20050057.
Texto completoWright, Lyndon C., Joachim Seybold, Annette Robichaud, Ian M. Adcock y Peter J. Barnes. "Phosphodiesterase expression in human epithelial cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, n.º 4 (1 de octubre de 1998): L694—L700. http://dx.doi.org/10.1152/ajplung.1998.275.4.l694.
Texto completoSasseville, M., F. K. Albuz, F. J. Richard y R. B. Gilchrist. "254. Evidences for a novel cAMP-phosphodiesterase expressed in the bovine ovarian follicle". Reproduction, Fertility and Development 20, n.º 9 (2008): 54. http://dx.doi.org/10.1071/srb08abs254.
Texto completoNeumann, Joachim, Rafaela Voss, Ulrich Laufs, Christian Werner y Ulrich Gergs. "Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H2-histamine-receptor activation in isolated atria of transgenic mice". Naunyn-Schmiedeberg's Archives of Pharmacology 394, n.º 6 (12 de febrero de 2021): 1215–29. http://dx.doi.org/10.1007/s00210-021-02052-y.
Texto completoTarpey, Siobhán B., Darrell R. Sawmiller, Claire Kelly, W. Joseph Thompson y Mary I. Townsley. "Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure". American Journal of Physiology-Lung Cellular and Molecular Physiology 284, n.º 5 (1 de mayo de 2003): L766—L773. http://dx.doi.org/10.1152/ajplung.00373.2002.
Texto completoPhillips, Peter G., Lu Long, Martin R. Wilkins y Nicholas W. Morrell. "cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling". American Journal of Physiology-Lung Cellular and Molecular Physiology 288, n.º 1 (enero de 2005): L103—L115. http://dx.doi.org/10.1152/ajplung.00095.2004.
Texto completoERDOGAN, Suat y Miles D. HOUSLAY. "Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant". Biochemical Journal 321, n.º 1 (1 de enero de 1997): 165–75. http://dx.doi.org/10.1042/bj3210165.
Texto completoSzczypka, Marianna. "Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions". International Journal of Molecular Sciences 21, n.º 17 (25 de agosto de 2020): 6118. http://dx.doi.org/10.3390/ijms21176118.
Texto completoTeng, Bunyan, Daniel N. Darlington y Andrew P. Cap. "Adenosine Regulation of cAMP through Phosphodiesterases". Blood 132, Supplement 1 (29 de noviembre de 2018): 2424. http://dx.doi.org/10.1182/blood-2018-99-114929.
Texto completoGranovski, Olexiy y Olena Boiarchuk. "FUNCTIONAL AND MUTATIONAL ANALYSIS OF THE IDENTIFICATION OF Pγ-BINDING RESIDUES ON PDE6α'". Grail of Science, n.º 28 (22 de junio de 2023): 157–61. http://dx.doi.org/10.36074/grail-of-science.09.06.2023.23.
Texto completoSeybold, Joachim, Dirk Thomas, Martin Witzenrath, Şengül Boral, Andreas C. Hocke, Alexander Bürger, Armin Hatzelmann et al. "Tumor necrosis factor-α–dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability". Blood 105, n.º 9 (1 de mayo de 2005): 3569–76. http://dx.doi.org/10.1182/blood-2004-07-2729.
Texto completoManns, J. M., K. J. Brennan, S. B. Sheth y R. W. Colman. "Differential Regulation of Human Platelet Responses by cGMP Inhibited and Stimulated cAMP Phosphodiesterases". Thrombosis and Haemostasis 87, n.º 05 (2002): 873–79. http://dx.doi.org/10.1055/s-0037-1613099.
Texto completoGermain, Nöella, Elisabeth Boichot, Jean-Michel Planquois y Vincent Lagente. "Reduced Airway Hyperresponsiveness by Phosphodiesterase 3 and 4 Inhibitors in Guinea-Pigs". Mediators of Inflammation 8, n.º 3 (1999): 153–57. http://dx.doi.org/10.1080/09629359990487.
Texto completoŚwierczek, Artur, Krzysztof Pociecha, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa y Elżbieta Wyska. "Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases". Pharmaceutics 14, n.º 5 (19 de mayo de 2022): 1090. http://dx.doi.org/10.3390/pharmaceutics14051090.
Texto completoSarfati, Marika, Véronique Mateo, Sylvie Baudet, Manuel Rubio, Christine Fernandez, Fréderic Davi, Jacques-Louis Binet, Jozo Delic y Hélène Merle-Béral. "Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells". Blood 101, n.º 1 (1 de enero de 2003): 265–69. http://dx.doi.org/10.1182/blood-2002-01-0075.
Texto completoReid, Ian A. "Role of Phosphodiesterase Isoenzymes in the Control of Renin Secretion: Effects of Selective Enzyme Inhibitors". Current Pharmaceutical Design 5, n.º 9 (enero de 1999): 725–35. http://dx.doi.org/10.2174/1381612805666230111201536.
Texto completoAbusnina, Abdurazzag, Thérèse Keravis, Qingwei Zhou, Hélène Justiniano, Annelise Lobstein y Claire Lugnier. "Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition". Thrombosis and Haemostasis 113, n.º 02 (marzo de 2015): 319–28. http://dx.doi.org/10.1160/th14-05-0454.
Texto completoLee, Dong I. y David A. Kass. "Phosphodiesterases and Cyclic GMP Regulation in Heart Muscle". Physiology 27, n.º 4 (agosto de 2012): 248–58. http://dx.doi.org/10.1152/physiol.00011.2012.
Texto completoFavot, Laure, Thérèse Keravis, Vincent Holl, Alain Bec y Claire Lugnier. "VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors". Thrombosis and Haemostasis 90, n.º 08 (2003): 334–43. http://dx.doi.org/10.1160/th03-02-0084.
Texto completoMokra, Daniela y Juraj Mokry. "Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?" International Journal of Molecular Sciences 22, n.º 4 (16 de febrero de 2021): 1929. http://dx.doi.org/10.3390/ijms22041929.
Texto completoCheng, Jingfei, Michael A. Thompson, Henry J. Walker, Catherine E. Gray, Gina M. Warner, Wei Zhou y Joseph P. Grande. "Lixazinone Stimulates Mitogenesis of Madin-Darby Canine Kidney Cells". Experimental Biology and Medicine 231, n.º 3 (marzo de 2006): 288–95. http://dx.doi.org/10.1177/153537020623100308.
Texto completoOgawa, Ryosuke, Michael B. Streiff, Artem Bugayenko y Gregory J. Kato. "Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells". Blood 99, n.º 9 (1 de mayo de 2002): 3390–97. http://dx.doi.org/10.1182/blood.v99.9.3390.
Texto completoCote, R. H. "Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5". International Journal of Impotence Research 16, S1 (junio de 2004): S28—S33. http://dx.doi.org/10.1038/sj.ijir.3901212.
Texto completoBloom, Timothy J. "Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle". Canadian Journal of Physiology and Pharmacology 83, n.º 11 (1 de noviembre de 2005): 1055–60. http://dx.doi.org/10.1139/y05-085.
Texto completoSpence, S., G. Rena, G. Sweeney y M. D. Houslay. "Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms". Biochemical Journal 310, n.º 3 (15 de septiembre de 1995): 975–82. http://dx.doi.org/10.1042/bj3100975.
Texto completoWang, Ya-Juan, Shun-De Song, Jun-Chun Chen, Xue-Feng Wang, Ya-Li Jiang, Qiang-Min Xie, Ji-Qiang Chen, Zi-Gang Li y Hui-Fang Tang. "Effects of InactivatedBordetella pertussison Phosphodiesterase in the Lung of Ovalbumin Sensitized and Challenged Rats". Pulmonary Medicine 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/581738.
Texto completoMussen, Femke, Jana Van Broeckhoven, Niels Hellings, Melissa Schepers y Tim Vanmierlo. "Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury". International Journal of Molecular Sciences 24, n.º 9 (2 de mayo de 2023): 8135. http://dx.doi.org/10.3390/ijms24098135.
Texto completoHovmöller, Sven, Linus Hovmöller Zou, Xiaodong Zou y Benjamin Grushko. "Structures of pseudo-decagonal approximants in Al−Co−Ni". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 370, n.º 1969 (28 de junio de 2012): 2949–59. http://dx.doi.org/10.1098/rsta.2011.0310.
Texto completoIvey, F. Douglas, Lili Wang, Didem Demirbas, Christina Allain y Charles S. Hoffman. "Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases". Journal of Biomolecular Screening 13, n.º 1 (26 de noviembre de 2007): 62–71. http://dx.doi.org/10.1177/1087057107312127.
Texto completoTulsian, Nikhil K., Valerie Jia-En Sin, Hwee-Ling Koh y Ganesh S. Anand. "Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity". International Journal of Molecular Sciences 22, n.º 10 (15 de mayo de 2021): 5242. http://dx.doi.org/10.3390/ijms22105242.
Texto completoRickles, Richard J., Laura Pierce, Thomas Giordano, Winnie F. Tam, Douglas W. McMillin, Kenneth C. Anderson, Constantine Mitsiades y Margaret S. Lee. "Adenosine A2A Receptor Agonism and PDE Inhibition: A Synergistic Multi-Target Mechanism Discovered through Systematic Combination Screening in Multiple Myeloma". Blood 112, n.º 11 (16 de noviembre de 2008): 847. http://dx.doi.org/10.1182/blood.v112.11.847.847.
Texto completoFoureau, Anna V. Ivanina, David M. Foureau, Carol J. Farhangfar y Kathryn F. Mileham. "Abstract 281: Phosphodiesterase 8/9 inhibition to sensitize squamous non-small cell lung cancer (NSCLC) to pemetrexed (PMX): A double-edge strategy". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 281. http://dx.doi.org/10.1158/1538-7445.am2023-281.
Texto completoZheng, Yang, Susanne Schroeder, Georgi K. Kanev, Sanaa S. Botros, Samia William, Abdel-Nasser A. Sabra, Louis Maes et al. "To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?" International Journal of Molecular Sciences 24, n.º 7 (6 de abril de 2023): 6817. http://dx.doi.org/10.3390/ijms24076817.
Texto completoNikawa, J., P. Sass y M. Wigler. "Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae". Molecular and Cellular Biology 7, n.º 10 (octubre de 1987): 3629–36. http://dx.doi.org/10.1128/mcb.7.10.3629-3636.1987.
Texto completoNikawa, J., P. Sass y M. Wigler. "Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae." Molecular and Cellular Biology 7, n.º 10 (octubre de 1987): 3629–36. http://dx.doi.org/10.1128/mcb.7.10.3629.
Texto completoXin, Wenkuan, Wei P. Feinstein, Andrea L. Britain, Cristhiaan D. Ochoa, Bing Zhu, Wito Richter, Silas J. Leavesley y Thomas C. Rich. "Estimating the magnitude of near-membrane PDE4 activity in living cells". American Journal of Physiology-Cell Physiology 309, n.º 6 (15 de septiembre de 2015): C415—C424. http://dx.doi.org/10.1152/ajpcell.00090.2015.
Texto completoKopanitsa, Liliya, Maksym V. Kopanitsa, Dewi Safitri, Graham Ladds y David S. Bailey. "Suppression of Proliferation of Human Glioblastoma Cells by Combined Phosphodiesterase and Multidrug Resistance-Associated Protein 1 Inhibition". International Journal of Molecular Sciences 22, n.º 18 (7 de septiembre de 2021): 9665. http://dx.doi.org/10.3390/ijms22189665.
Texto completoDay, Jonathan P., Miles D. Houslay y Shireen-A. Davies. "A novel role for a Drosophila homologue of cGMP-specific phosphodiesterase in the active transport of cGMP". Biochemical Journal 393, n.º 2 (23 de diciembre de 2005): 481–88. http://dx.doi.org/10.1042/bj20051505.
Texto completoMeima, Marcel E., Ricardo M. Biondi y Pauline Schaap. "Identification of a Novel Type of cGMP Phosphodiesterase That Is Defective in the ChemotacticstmFMutants". Molecular Biology of the Cell 13, n.º 11 (noviembre de 2002): 3870–77. http://dx.doi.org/10.1091/mbc.e02-05-0285.
Texto completoHanson, Kimberly A., James W. Ziegler, Sergei D. Rybalkin, Jim W. Miller, Steven H. Abman y William R. Clarke. "Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, n.º 5 (1 de noviembre de 1998): L931—L941. http://dx.doi.org/10.1152/ajplung.1998.275.5.l931.
Texto completoMurray, Fiona, Hemal H. Patel, Ryan Y. S. Suda, Shen Zhang, Patricia A. Thistlethwaite, Jason X. J. Yuan y Paul A. Insel. "Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1". American Journal of Physiology-Lung Cellular and Molecular Physiology 292, n.º 1 (enero de 2007): L294—L303. http://dx.doi.org/10.1152/ajplung.00190.2006.
Texto completoBlanco-Rivero, Javier y Fabiano E. Xavier. "Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases". Current Pharmaceutical Design 26, n.º 30 (4 de septiembre de 2020): 3633–51. http://dx.doi.org/10.2174/1381612826666200403172736.
Texto completoShen, Kunyu, David W. Johnson y Glenda C. Gobe. "The role of cGMP and its signaling pathways in kidney disease". American Journal of Physiology-Renal Physiology 311, n.º 4 (1 de octubre de 2016): F671—F681. http://dx.doi.org/10.1152/ajprenal.00042.2016.
Texto completoOkatan, Esma N. y Belma Turan. "The contribution of phosphodiesterases to cardiac dysfunction in rats with metabolic syndrome induced by a high-carbohydrate diet". Canadian Journal of Physiology and Pharmacology 97, n.º 11 (noviembre de 2019): 1064–72. http://dx.doi.org/10.1139/cjpp-2019-0006.
Texto completoWang, Huanchen, Stefan Kunz, Gong Chen, Thomas Seebeck, Yiqian Wan, Howard Robinson, Sibylla Martinelli y Hengming Ke. "Biological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective Inhibitors". Journal of Biological Chemistry 287, n.º 15 (21 de febrero de 2012): 11788–97. http://dx.doi.org/10.1074/jbc.m111.326777.
Texto completoMaronde, Erik. "Influence of Phosphodiesterase Inhibition on CRE- and EGR1-Dependent Transcription in a Mouse Hippocampal Cell Line". International Journal of Molecular Sciences 21, n.º 22 (17 de noviembre de 2020): 8658. http://dx.doi.org/10.3390/ijms21228658.
Texto completoSu, Yi-Hsien y Victor D. Vacquier. "Cyclic GMP-specific Phosphodiesterase-5 Regulates Motility of Sea Urchin Spermatozoa". Molecular Biology of the Cell 17, n.º 1 (enero de 2006): 114–21. http://dx.doi.org/10.1091/mbc.e05-08-0820.
Texto completoMendoza, G. A. y F. Treves. "linear PDE". Duke Mathematical Journal 63, n.º 2 (julio de 1991): 355–77. http://dx.doi.org/10.1215/s0012-7094-91-06315-5.
Texto completoOliveira, Tiago Roux y Miroslav Krstic. "Extremum seeking boundary control for PDE–PDE cascades". Systems & Control Letters 155 (septiembre de 2021): 105004. http://dx.doi.org/10.1016/j.sysconle.2021.105004.
Texto completo